Cite Filings / FULC / 0001104659-20-020454
Feed Companies Filings Check
Sign in
SC 13G/A

Amended Statement of Ownership

Fulcrum Therapeutics, Inc. · Filed 2020-02-14 · Acc 0001104659-20-020454

Documents 1

  • SC 13G/A Amended Statement of Ownership , tm207694d2_sc13ga.htm

Around this filing

  • 2021-02-08 SC 13G/A Amended Statement of Ownership
  • 2020-02-20 SC 13G Amended Statement of Ownership
  • 2020-02-20 4 Gould Robert J sold 2,500 shares at $20.00 ($50,000)
  • 2020-02-20 4 Chief Scientific Officer sold 6,088 shares at $20.00 ($121,760)
  • 2020-02-14 SC 13G Amended Statement of Ownership
  • 2020-02-14 SC 13G/A Amended Statement of Ownership
  • 2020-02-07 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · ADAR1 Capital Management, LLC 8.7%
  2. 2026-11-16 SCHEDULE 13G/A · EcoR1 Capital, LLC 8.9%
  3. 2026-11-13 SCHEDULE 13G/A · Nantahala Capital Management, LLC 8.62%
  4. 2026-11-13 SCHEDULE 13G/A · Montanova Capital, LLC 0%
Loading tm207694d2_sc13ga.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…